UK markets closed
NIKKEI 225
38,202.37 -632.73 (-1.63%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
79.22 +0.84 (+1.07%) GOLD FUTURES
2,316.10 -8.10 (-0.35%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,205.48 -1,292.34 (-2.56%)
Artelo Biosciences, Inc. (ARTL)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 4.20M |
| Enterprise value | -6.21M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.36 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | 0.67 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.20 |
| 52-week change 3 | -24.74% |
| S&P500 52-week change 3 | 25.38% |
| 52-week high 3 | 2.9800 |
| 52-week low 3 | 1.1500 |
| 50-day moving average 3 | 1.4504 |
| 200-day moving average 3 | 1.5168 |
Share statistics
| Avg vol (3-month) 3 | 14.65k |
| Avg vol (10-day) 3 | 7.61k |
| Shares outstanding 5 | 3.23M |
| Implied shares outstanding 6 | 3.23M |
| Float 8 | 3.2M |
| % held by insiders 1 | 0.83% |
| % held by institutions 1 | 0.78% |
| Shares short (15 Apr 2024) 4 | 6.08k |
| Short ratio (15 Apr 2024) 4 | 0.42 |
| Short % of float (15 Apr 2024) 4 | 0.19% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.19% |
| Shares short (prior month 15 Mar 2024) 4 | 20.19k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 21 Jun 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:15 |
| Last split date 3 | 10 Aug 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -37.09% |
| Return on equity (ttm) | -59.63% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -9.29M |
| Diluted EPS (ttm) | -3.1400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 10.43M |
| Total cash per share (mrq) | 3.23 |
| Total debt (mrq) | 23k |
| Total debt/equity (mrq) | 0.20% |
| Current ratio (mrq) | 8.51 |
| Book value per share (mrq) | 3.68 |
Cash flow statement
| Operating cash flow (ttm) | -8.21M |
| Levered free cash flow (ttm) | -4.64M |
© 2024 Yahoo. All rights reserved.